Sustained circulation of yellow fever virus in Cameroon: an analysis of laboratory surveillance data, 2010–2020

Abstract Background The re-emergence of yellow fever poses a serious public health risk to unimmunized communities in the tropical regions of Africa and South America and unvaccinated travelers visiting these regions. This risk is further accentuated by the likely spread of the virus to areas with p...

Full description

Bibliographic Details
Main Authors: Fredy Brice Simo Nemg, Ngu Njei Abanda, Martial Gide Yonga, Diane Ouapi, Ivis Ewang Samme, Marlise Dontsop Djoumetio, Marie Claire Endegue-Zanga, Maurice Demanou, Richard Njouom
Format: Article
Language:English
Published: BMC 2022-04-01
Series:BMC Infectious Diseases
Subjects:
Online Access:https://doi.org/10.1186/s12879-022-07407-1
_version_ 1828370617887358976
author Fredy Brice Simo Nemg
Ngu Njei Abanda
Martial Gide Yonga
Diane Ouapi
Ivis Ewang Samme
Marlise Dontsop Djoumetio
Marie Claire Endegue-Zanga
Maurice Demanou
Richard Njouom
author_facet Fredy Brice Simo Nemg
Ngu Njei Abanda
Martial Gide Yonga
Diane Ouapi
Ivis Ewang Samme
Marlise Dontsop Djoumetio
Marie Claire Endegue-Zanga
Maurice Demanou
Richard Njouom
author_sort Fredy Brice Simo Nemg
collection DOAJ
description Abstract Background The re-emergence of yellow fever poses a serious public health risk to unimmunized communities in the tropical regions of Africa and South America and unvaccinated travelers visiting these regions. This risk is further accentuated by the likely spread of the virus to areas with potential for yellow fever transmission such as in Asia, Europe, and North America. To mitigate this risk, surveillance of yellow fever is pivotal. We performed an analysis of laboratory-based surveillance of yellow fever suspected cases in Cameroon during 2010–2020 to characterize the epidemiology of yellow fever cases and define health districts at high risk. Method We reviewed IgM capture ELISA and plaque reduction neutralization test (PRNT) test results of all suspected yellow fever patients analyzed at Centre Pasteur of Cameroon, the national yellow fever testing laboratory, during 2010–2020. Results Of the 20,261 yellow fever suspected patient’s samples that were tested, yellow fever IgM antibodies were detected in 360 patients representing an annual average of 33 cases/year. A major increase in YF IgM positive cases was observed in 2015 and in 2016 followed by a decrease in cases to below pre-2015 levels. The majority of the 2015 cases occurred during the latter part of the year while those in 2016, occurred between February and May. This trend may be due to an increase in transmission that began in late 2015 and continued to early 2016 or due to two separate transmission events. In 2016, where the highest number of cases were detected, 60 health districts in the 10 regions of Cameroon were affected with the Littoral, Northwest and, Far North regions being the most affected. After 2016, the number of detected yellow fever IgM positive cases dropped. Conclusion Our study shows that yellow fever transmission continues to persist and seems to be occurring all over Cameroon with all 10 regions under surveillance reporting a case. Preventive measures such as mass vaccination campaigns and routine childhood immunizations are urgently needed to increase population immunity. The diagnostic limitations in our analysis highlight the need to strengthen laboratory capacity and improve case investigations.
first_indexed 2024-04-14T06:40:51Z
format Article
id doaj.art-3419e548184446828440e83aab519dce
institution Directory Open Access Journal
issn 1471-2334
language English
last_indexed 2024-04-14T06:40:51Z
publishDate 2022-04-01
publisher BMC
record_format Article
series BMC Infectious Diseases
spelling doaj.art-3419e548184446828440e83aab519dce2022-12-22T02:07:20ZengBMCBMC Infectious Diseases1471-23342022-04-0122111010.1186/s12879-022-07407-1Sustained circulation of yellow fever virus in Cameroon: an analysis of laboratory surveillance data, 2010–2020Fredy Brice Simo Nemg0Ngu Njei Abanda1Martial Gide Yonga2Diane Ouapi3Ivis Ewang Samme4Marlise Dontsop Djoumetio5Marie Claire Endegue-Zanga6Maurice Demanou7Richard Njouom8Department of Biochemistry, University of Yaounde 1Virology Unit, Virology Service, Centre Pasteur of CameroonVirology Unit, Virology Service, Centre Pasteur of CameroonVirology Unit, Virology Service, Centre Pasteur of CameroonExpanded Programme on Immunization, Ministry of Public HealthWorld Health OrganizationVirology Unit, Virology Service, Centre Pasteur of CameroonWorld Health Organization, Inter-Country Support Team West AfricaVirology Unit, Virology Service, Centre Pasteur of CameroonAbstract Background The re-emergence of yellow fever poses a serious public health risk to unimmunized communities in the tropical regions of Africa and South America and unvaccinated travelers visiting these regions. This risk is further accentuated by the likely spread of the virus to areas with potential for yellow fever transmission such as in Asia, Europe, and North America. To mitigate this risk, surveillance of yellow fever is pivotal. We performed an analysis of laboratory-based surveillance of yellow fever suspected cases in Cameroon during 2010–2020 to characterize the epidemiology of yellow fever cases and define health districts at high risk. Method We reviewed IgM capture ELISA and plaque reduction neutralization test (PRNT) test results of all suspected yellow fever patients analyzed at Centre Pasteur of Cameroon, the national yellow fever testing laboratory, during 2010–2020. Results Of the 20,261 yellow fever suspected patient’s samples that were tested, yellow fever IgM antibodies were detected in 360 patients representing an annual average of 33 cases/year. A major increase in YF IgM positive cases was observed in 2015 and in 2016 followed by a decrease in cases to below pre-2015 levels. The majority of the 2015 cases occurred during the latter part of the year while those in 2016, occurred between February and May. This trend may be due to an increase in transmission that began in late 2015 and continued to early 2016 or due to two separate transmission events. In 2016, where the highest number of cases were detected, 60 health districts in the 10 regions of Cameroon were affected with the Littoral, Northwest and, Far North regions being the most affected. After 2016, the number of detected yellow fever IgM positive cases dropped. Conclusion Our study shows that yellow fever transmission continues to persist and seems to be occurring all over Cameroon with all 10 regions under surveillance reporting a case. Preventive measures such as mass vaccination campaigns and routine childhood immunizations are urgently needed to increase population immunity. The diagnostic limitations in our analysis highlight the need to strengthen laboratory capacity and improve case investigations.https://doi.org/10.1186/s12879-022-07407-1Yellow feverCameroonSurveillanceYellow fever serologyYellow fever high risk districts
spellingShingle Fredy Brice Simo Nemg
Ngu Njei Abanda
Martial Gide Yonga
Diane Ouapi
Ivis Ewang Samme
Marlise Dontsop Djoumetio
Marie Claire Endegue-Zanga
Maurice Demanou
Richard Njouom
Sustained circulation of yellow fever virus in Cameroon: an analysis of laboratory surveillance data, 2010–2020
BMC Infectious Diseases
Yellow fever
Cameroon
Surveillance
Yellow fever serology
Yellow fever high risk districts
title Sustained circulation of yellow fever virus in Cameroon: an analysis of laboratory surveillance data, 2010–2020
title_full Sustained circulation of yellow fever virus in Cameroon: an analysis of laboratory surveillance data, 2010–2020
title_fullStr Sustained circulation of yellow fever virus in Cameroon: an analysis of laboratory surveillance data, 2010–2020
title_full_unstemmed Sustained circulation of yellow fever virus in Cameroon: an analysis of laboratory surveillance data, 2010–2020
title_short Sustained circulation of yellow fever virus in Cameroon: an analysis of laboratory surveillance data, 2010–2020
title_sort sustained circulation of yellow fever virus in cameroon an analysis of laboratory surveillance data 2010 2020
topic Yellow fever
Cameroon
Surveillance
Yellow fever serology
Yellow fever high risk districts
url https://doi.org/10.1186/s12879-022-07407-1
work_keys_str_mv AT fredybricesimonemg sustainedcirculationofyellowfevervirusincameroonananalysisoflaboratorysurveillancedata20102020
AT ngunjeiabanda sustainedcirculationofyellowfevervirusincameroonananalysisoflaboratorysurveillancedata20102020
AT martialgideyonga sustainedcirculationofyellowfevervirusincameroonananalysisoflaboratorysurveillancedata20102020
AT dianeouapi sustainedcirculationofyellowfevervirusincameroonananalysisoflaboratorysurveillancedata20102020
AT ivisewangsamme sustainedcirculationofyellowfevervirusincameroonananalysisoflaboratorysurveillancedata20102020
AT marlisedontsopdjoumetio sustainedcirculationofyellowfevervirusincameroonananalysisoflaboratorysurveillancedata20102020
AT marieclaireendeguezanga sustainedcirculationofyellowfevervirusincameroonananalysisoflaboratorysurveillancedata20102020
AT mauricedemanou sustainedcirculationofyellowfevervirusincameroonananalysisoflaboratorysurveillancedata20102020
AT richardnjouom sustainedcirculationofyellowfevervirusincameroonananalysisoflaboratorysurveillancedata20102020